TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Biotechnological Drugs Market, Global Outlook and Forecast 2023-2032

Biotechnological Drugs Market, Global Outlook and Forecast 2023-2032

  • Category:Life Sciences
  • Published on : 01 March 2023
  • Pages :107
  • Formats:
  • Report Code:SMR-7586386

This report aims to provide a comprehensive presentation of the global market for Biotechnological Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biotechnological Drugs. This report contains market size and forecasts of Biotechnological Drugs in global, including the following market information:
Global Biotechnological Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Biotechnological Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Genetically Engineered Drugs Segment to Reach $ Million by 2032, with a % CAGR in next six years.
The global key manufacturers of Biotechnological Drugs include 3SBIO, Anhui Anke Biotechnology, Beijing SL Pharmaceutical, Biotech Pharmaceutical, Cadila Healthcare, Celgen Biopharma, Celltrion, Dr Reddy?s and GeneScience Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biotechnological Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biotechnological Drugs Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Biotechnological Drugs Market Segment Percentages, by Type, 2022 (%)
Genetically Engineered Drugs
Therapeutic Monoclonal Antibody Drugs
Gene Therapy and Nucleic Acid Drugs
Genetically Engineered Vaccines
Other
Global Biotechnological Drugs Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Biotechnological Drugs Market Segment Percentages, by Application, 2022 (%)
Tumor
Autoimmune Disease
Other
Global Biotechnological Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Biotechnological Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biotechnological Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Biotechnological Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3SBIO
Anhui Anke Biotechnology
Beijing SL Pharmaceutical
Biotech Pharmaceutical
Cadila Healthcare
Celgen Biopharma
Celltrion
Dr Reddy?s
GeneScience Pharmaceuticals
Hisun Pharma
Jiangsu Sihuan Bioengineering
Novartis (Sandoz)
Pfizer (Hospira)
Shanghai Lansheng Guojian Pharmaceutical
Shenzhen Neptunus Interlong Bio-Technique
Tonghua Dongbao Pharmaceutical
Torrent Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biotechnological Drugs, market overview.
Chapter 2: Global Biotechnological Drugs market size in revenue.
Chapter 3: Detailed analysis of Biotechnological Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biotechnological Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Biotechnological Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biotechnological Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biotechnological Drugs Overall Market Size
2.1 Global Biotechnological Drugs Market Size: 2022 VS 2032
2.2 Global Biotechnological Drugs Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biotechnological Drugs Players in Global Market
3.2 Top Global Biotechnological Drugs Companies Ranked by Revenue
3.3 Global Biotechnological Drugs Revenue by Companies
3.4 Top 3 and Top 5 Biotechnological Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Biotechnological Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biotechnological Drugs Players in Global Market
3.6.1 List of Global Tier 1 Biotechnological Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Biotechnological Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Biotechnological Drugs Market Size Markets, 2022 & 2032
4.1.2 Genetically Engineered Drugs
4.1.3 Therapeutic Monoclonal Antibody Drugs
4.1.4 Gene Therapy and Nucleic Acid Drugs
4.1.5 Genetically Engineered Vaccines
4.1.6 Other
4.2 By Type - Global Biotechnological Drugs Revenue & Forecasts
4.2.1 By Type - Global Biotechnological Drugs Revenue, 2018-2023
4.2.2 By Type - Global Biotechnological Drugs Revenue, 2024-2032
4.2.3 By Type - Global Biotechnological Drugs Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biotechnological Drugs Market Size, 2022 & 2032
5.1.2 Tumor
5.1.3 Autoimmune Disease
5.1.4 Other
5.2 By Application - Global Biotechnological Drugs Revenue & Forecasts
5.2.1 By Application - Global Biotechnological Drugs Revenue, 2018-2023
5.2.2 By Application - Global Biotechnological Drugs Revenue, 2024-2032
5.2.3 By Application - Global Biotechnological Drugs Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Biotechnological Drugs Market Size, 2022 & 2032
6.2 By Region - Global Biotechnological Drugs Revenue & Forecasts
6.2.1 By Region - Global Biotechnological Drugs Revenue, 2018-2023
6.2.2 By Region - Global Biotechnological Drugs Revenue, 2024-2032
6.2.3 By Region - Global Biotechnological Drugs Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Biotechnological Drugs Revenue, 2018-2032
6.3.2 US Biotechnological Drugs Market Size, 2018-2032
6.3.3 Canada Biotechnological Drugs Market Size, 2018-2032
6.3.4 Mexico Biotechnological Drugs Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Biotechnological Drugs Revenue, 2018-2032
6.4.2 Germany Biotechnological Drugs Market Size, 2018-2032
6.4.3 France Biotechnological Drugs Market Size, 2018-2032
6.4.4 U.K. Biotechnological Drugs Market Size, 2018-2032
6.4.5 Italy Biotechnological Drugs Market Size, 2018-2032
6.4.6 Russia Biotechnological Drugs Market Size, 2018-2032
6.4.7 Nordic Countries Biotechnological Drugs Market Size, 2018-2032
6.4.8 Benelux Biotechnological Drugs Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Biotechnological Drugs Revenue, 2018-2032
6.5.2 China Biotechnological Drugs Market Size, 2018-2032
6.5.3 Japan Biotechnological Drugs Market Size, 2018-2032
6.5.4 South Korea Biotechnological Drugs Market Size, 2018-2032
6.5.5 Southeast Asia Biotechnological Drugs Market Size, 2018-2032
6.5.6 India Biotechnological Drugs Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Biotechnological Drugs Revenue, 2018-2032
6.6.2 Brazil Biotechnological Drugs Market Size, 2018-2032
6.6.3 Argentina Biotechnological Drugs Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biotechnological Drugs Revenue, 2018-2032
6.7.2 Turkey Biotechnological Drugs Market Size, 2018-2032
6.7.3 Israel Biotechnological Drugs Market Size, 2018-2032
6.7.4 Saudi Arabia Biotechnological Drugs Market Size, 2018-2032
6.7.5 UAE Biotechnological Drugs Market Size, 2018-2032
7 Biotechnological Drugs Companies Profiles
7.1 3SBIO
7.1.1 3SBIO Company Summary
7.1.2 3SBIO Business Overview
7.1.3 3SBIO Biotechnological Drugs Major Product Offerings
7.1.4 3SBIO Biotechnological Drugs Revenue in Global Market (2018-2023)
7.1.5 3SBIO Key News & Latest Developments
7.2 Anhui Anke Biotechnology
7.2.1 Anhui Anke Biotechnology Company Summary
7.2.2 Anhui Anke Biotechnology Business Overview
7.2.3 Anhui Anke Biotechnology Biotechnological Drugs Major Product Offerings
7.2.4 Anhui Anke Biotechnology Biotechnological Drugs Revenue in Global Market (2018-2023)
7.2.5 Anhui Anke Biotechnology Key News & Latest Developments
7.3 Beijing SL Pharmaceutical
7.3.1 Beijing SL Pharmaceutical Company Summary
7.3.2 Beijing SL Pharmaceutical Business Overview
7.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Major Product Offerings
7.3.4 Beijing SL Pharmaceutical Biotechnological Drugs Revenue in Global Market (2018-2023)
7.3.5 Beijing SL Pharmaceutical Key News & Latest Developments
7.4 Biotech Pharmaceutical
7.4.1 Biotech Pharmaceutical Company Summary
7.4.2 Biotech Pharmaceutical Business Overview
7.4.3 Biotech Pharmaceutical Biotechnological Drugs Major Product Offerings
7.4.4 Biotech Pharmaceutical Biotechnological Drugs Revenue in Global Market (2018-2023)
7.4.5 Biotech Pharmaceutical Key News & Latest Developments
7.5 Cadila Healthcare
7.5.1 Cadila Healthcare Company Summary
7.5.2 Cadila Healthcare Business Overview
7.5.3 Cadila Healthcare Biotechnological Drugs Major Product Offerings
7.5.4 Cadila Healthcare Biotechnological Drugs Revenue in Global Market (2018-2023)
7.5.5 Cadila Healthcare Key News & Latest Developments
7.6 Celgen Biopharma
7.6.1 Celgen Biopharma Company Summary
7.6.2 Celgen Biopharma Business Overview
7.6.3 Celgen Biopharma Biotechnological Drugs Major Product Offerings
7.6.4 Celgen Biopharma Biotechnological Drugs Revenue in Global Market (2018-2023)
7.6.5 Celgen Biopharma Key News & Latest Developments
7.7 Celltrion
7.7.1 Celltrion Company Summary
7.7.2 Celltrion Business Overview
7.7.3 Celltrion Biotechnological Drugs Major Product Offerings
7.7.4 Celltrion Biotechnological Drugs Revenue in Global Market (2018-2023)
7.7.5 Celltrion Key News & Latest Developments
7.8 Dr Reddy?s
7.8.1 Dr Reddy?s Company Summary
7.8.2 Dr Reddy?s Business Overview
7.8.3 Dr Reddy?s Biotechnological Drugs Major Product Offerings
7.8.4 Dr Reddy?s Biotechnological Drugs Revenue in Global Market (2018-2023)
7.8.5 Dr Reddy?s Key News & Latest Developments
7.9 GeneScience Pharmaceuticals
7.9.1 GeneScience Pharmaceuticals Company Summary
7.9.2 GeneScience Pharmaceuticals Business Overview
7.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Major Product Offerings
7.9.4 GeneScience Pharmaceuticals Biotechnological Drugs Revenue in Global Market (2018-2023)
7.9.5 GeneScience Pharmaceuticals Key News & Latest Developments
7.10 Hisun Pharma
7.10.1 Hisun Pharma Company Summary
7.10.2 Hisun Pharma Business Overview
7.10.3 Hisun Pharma Biotechnological Drugs Major Product Offerings
7.10.4 Hisun Pharma Biotechnological Drugs Revenue in Global Market (2018-2023)
7.10.5 Hisun Pharma Key News & Latest Developments
7.11 Jiangsu Sihuan Bioengineering
7.11.1 Jiangsu Sihuan Bioengineering Company Summary
7.11.2 Jiangsu Sihuan Bioengineering Business Overview
7.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Major Product Offerings
7.11.4 Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue in Global Market (2018-2023)
7.11.5 Jiangsu Sihuan Bioengineering Key News & Latest Developments
7.12 Novartis (Sandoz)
7.12.1 Novartis (Sandoz) Company Summary
7.12.2 Novartis (Sandoz) Business Overview
7.12.3 Novartis (Sandoz) Biotechnological Drugs Major Product Offerings
7.12.4 Novartis (Sandoz) Biotechnological Drugs Revenue in Global Market (2018-2023)
7.12.5 Novartis (Sandoz) Key News & Latest Developments
7.13 Pfizer (Hospira)
7.13.1 Pfizer (Hospira) Company Summary
7.13.2 Pfizer (Hospira) Business Overview
7.13.3 Pfizer (Hospira) Biotechnological Drugs Major Product Offerings
7.13.4 Pfizer (Hospira) Biotechnological Drugs Revenue in Global Market (2018-2023)
7.13.5 Pfizer (Hospira) Key News & Latest Developments
7.14 Shanghai Lansheng Guojian Pharmaceutical
7.14.1 Shanghai Lansheng Guojian Pharmaceutical Company Summary
7.14.2 Shanghai Lansheng Guojian Pharmaceutical Business Overview
7.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Major Product Offerings
7.14.4 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue in Global Market (2018-2023)
7.14.5 Shanghai Lansheng Guojian Pharmaceutical Key News & Latest Developments
7.15 Shenzhen Neptunus Interlong Bio-Technique
7.15.1 Shenzhen Neptunus Interlong Bio-Technique Company Summary
7.15.2 Shenzhen Neptunus Interlong Bio-Technique Business Overview
7.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Major Product Offerings
7.15.4 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue in Global Market (2018-2023)
7.15.5 Shenzhen Neptunus Interlong Bio-Technique Key News & Latest Developments
7.16 Tonghua Dongbao Pharmaceutical
7.16.1 Tonghua Dongbao Pharmaceutical Company Summary
7.16.2 Tonghua Dongbao Pharmaceutical Business Overview
7.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Major Product Offerings
7.16.4 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue in Global Market (2018-2023)
7.16.5 Tonghua Dongbao Pharmaceutical Key News & Latest Developments
7.17 Torrent Pharmaceuticals
7.17.1 Torrent Pharmaceuticals Company Summary
7.17.2 Torrent Pharmaceuticals Business Overview
7.17.3 Torrent Pharmaceuticals Biotechnological Drugs Major Product Offerings
7.17.4 Torrent Pharmaceuticals Biotechnological Drugs Revenue in Global Market (2018-2023)
7.17.5 Torrent Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Biotechnological Drugs Market Opportunities & Trends in Global Market
Table 2. Biotechnological Drugs Market Drivers in Global Market
Table 3. Biotechnological Drugs Market Restraints in Global Market
Table 4. Key Players of Biotechnological Drugs in Global Market
Table 5. Top Biotechnological Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Biotechnological Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Biotechnological Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Biotechnological Drugs Product Type
Table 9. List of Global Tier 1 Biotechnological Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biotechnological Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Biotechnological Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Biotechnological Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Biotechnological Drugs Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Biotechnological Drugs Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Biotechnological Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Biotechnological Drugs Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Biotechnological Drugs Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Biotechnological Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Biotechnological Drugs Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Biotechnological Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Biotechnological Drugs Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Biotechnological Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Biotechnological Drugs Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Biotechnological Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Biotechnological Drugs Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Biotechnological Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Biotechnological Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Biotechnological Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Biotechnological Drugs Revenue, (US$, Mn), 2024-2032
Table 30. 3SBIO Company Summary
Table 31. 3SBIO Biotechnological Drugs Product Offerings
Table 32. 3SBIO Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. 3SBIO Key News & Latest Developments
Table 34. Anhui Anke Biotechnology Company Summary
Table 35. Anhui Anke Biotechnology Biotechnological Drugs Product Offerings
Table 36. Anhui Anke Biotechnology Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Anhui Anke Biotechnology Key News & Latest Developments
Table 38. Beijing SL Pharmaceutical Company Summary
Table 39. Beijing SL Pharmaceutical Biotechnological Drugs Product Offerings
Table 40. Beijing SL Pharmaceutical Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Beijing SL Pharmaceutical Key News & Latest Developments
Table 42. Biotech Pharmaceutical Company Summary
Table 43. Biotech Pharmaceutical Biotechnological Drugs Product Offerings
Table 44. Biotech Pharmaceutical Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Biotech Pharmaceutical Key News & Latest Developments
Table 46. Cadila Healthcare Company Summary
Table 47. Cadila Healthcare Biotechnological Drugs Product Offerings
Table 48. Cadila Healthcare Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Cadila Healthcare Key News & Latest Developments
Table 50. Celgen Biopharma Company Summary
Table 51. Celgen Biopharma Biotechnological Drugs Product Offerings
Table 52. Celgen Biopharma Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Celgen Biopharma Key News & Latest Developments
Table 54. Celltrion Company Summary
Table 55. Celltrion Biotechnological Drugs Product Offerings
Table 56. Celltrion Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Celltrion Key News & Latest Developments
Table 58. Dr Reddy?s Company Summary
Table 59. Dr Reddy?s Biotechnological Drugs Product Offerings
Table 60. Dr Reddy?s Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Dr Reddy?s Key News & Latest Developments
Table 62. GeneScience Pharmaceuticals Company Summary
Table 63. GeneScience Pharmaceuticals Biotechnological Drugs Product Offerings
Table 64. GeneScience Pharmaceuticals Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. GeneScience Pharmaceuticals Key News & Latest Developments
Table 66. Hisun Pharma Company Summary
Table 67. Hisun Pharma Biotechnological Drugs Product Offerings
Table 68. Hisun Pharma Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Hisun Pharma Key News & Latest Developments
Table 70. Jiangsu Sihuan Bioengineering Company Summary
Table 71. Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Offerings
Table 72. Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Jiangsu Sihuan Bioengineering Key News & Latest Developments
Table 74. Novartis (Sandoz) Company Summary
Table 75. Novartis (Sandoz) Biotechnological Drugs Product Offerings
Table 76. Novartis (Sandoz) Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Novartis (Sandoz) Key News & Latest Developments
Table 78. Pfizer (Hospira) Company Summary
Table 79. Pfizer (Hospira) Biotechnological Drugs Product Offerings
Table 80. Pfizer (Hospira) Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Pfizer (Hospira) Key News & Latest Developments
Table 82. Shanghai Lansheng Guojian Pharmaceutical Company Summary
Table 83. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Offerings
Table 84. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Shanghai Lansheng Guojian Pharmaceutical Key News & Latest Developments
Table 86. Shenzhen Neptunus Interlong Bio-Technique Company Summary
Table 87. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Offerings
Table 88. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Shenzhen Neptunus Interlong Bio-Technique Key News & Latest Developments
Table 90. Tonghua Dongbao Pharmaceutical Company Summary
Table 91. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Offerings
Table 92. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 93. Tonghua Dongbao Pharmaceutical Key News & Latest Developments
Table 94. Torrent Pharmaceuticals Company Summary
Table 95. Torrent Pharmaceuticals Biotechnological Drugs Product Offerings
Table 96. Torrent Pharmaceuticals Biotechnological Drugs Revenue (US$, Mn) & (2018-2023)
Table 97. Torrent Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Biotechnological Drugs Segment by Type in 2022
Figure 2. Biotechnological Drugs Segment by Application in 2022
Figure 3. Global Biotechnological Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biotechnological Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Biotechnological Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biotechnological Drugs Revenue in 2022
Figure 8. By Type - Global Biotechnological Drugs Revenue Market Share, 2018-2032
Figure 9. By Application - Global Biotechnological Drugs Revenue Market Share, 2018-2032
Figure 10. By Type - Global Biotechnological Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Biotechnological Drugs Revenue Market Share, 2018-2032
Figure 12. By Application - Global Biotechnological Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Biotechnological Drugs Revenue Market Share, 2018-2032
Figure 14. By Region - Global Biotechnological Drugs Revenue Market Share, 2018-2032
Figure 15. By Country - North America Biotechnological Drugs Revenue Market Share, 2018-2032
Figure 16. US Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Biotechnological Drugs Revenue Market Share, 2018-2032
Figure 20. Germany Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 21. France Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Biotechnological Drugs Revenue Market Share, 2018-2032
Figure 28. China Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. India Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Biotechnological Drugs Revenue Market Share, 2018-2032
Figure 34. Brazil Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Biotechnological Drugs Revenue Market Share, 2018-2032
Figure 37. Turkey Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Biotechnological Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. 3SBIO Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Anhui Anke Biotechnology Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Beijing SL Pharmaceutical Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Biotech Pharmaceutical Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Cadila Healthcare Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Celgen Biopharma Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Celltrion Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Dr Reddy?s Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GeneScience Pharmaceuticals Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Hisun Pharma Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Novartis (Sandoz) Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Pfizer (Hospira) Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Torrent Pharmaceuticals Biotechnological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

Offer REPORT BUYING OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount